Lantern Pharma Inc. LTRN:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/05/22 EDT
5.51quote price arrow up+0.24 (+4.55%)
Volume
54,547
52 week range
4.76 - 14.82
Loading...
  • Open5.25
  • Day High5.49
  • Day Low5.16
  • Prev Close5.27
  • 52 Week High14.82
  • 52 Week High Date08/30/21
  • 52 Week Low4.76
  • 52 Week Low Date07/15/22

Key Stats

  • Market Cap59.67M
  • Shares Out10.83M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-31.58

KEY STATS

  • Open5.25
  • Day High5.49
  • Day Low5.16
  • Prev Close5.27
  • 52 Week High14.82
  • 52 Week High Date08/30/21
  • 52 Week Low4.76
  • 52 Week Low Date07/15/22
  • Market Cap59.67M
  • Shares Out10.83M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-31.58

RATIOS/PROFITABILITY

  • EPS (TTM)-1.27
  • P/E (TTM)-4.35
  • Fwd P/E (NTM)-2.69
  • EBITDA (TTM)-14.198M
  • ROE (TTM)-19.09%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/08/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lantern Pharma Inc.

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Lantern Pharma Inc. is a clinical stage biopharmaceutical company focused on using artificial intelligence (AI), machine learning and genomic data to streamline the drug development process. The Company's therapies portfolio consists of small molecule drug candidates and new compounds, which it is developing with the assistance of its AI platform and its biomarker driven approach. Its products include LP-100, LP-300, LP-184, and LP-284, and an Antibody Drug Conjugate (ADC)...
Donald Keyser J.D., Ph.D.
Independent Chairman of the Board
Panna Sharma
President, Chief Executive Officer, Director
David Margrave J.D.
Chief Financial Officer, Secretary
Address
1920 MCKINNEY AVENUE, 7TH FLOOR
Dallas, TX
75201
United States

Top Peers

SYMBOLLASTCHG%CHG
FRLN
Freeline Therapeutics Holdings PLC
0.8724-0.0176-1.9775%
NMTR
9 Meters Biopharma Inc
0.2659+0.0051+1.96%
MIRO
Miromatrix Medical Inc
2.78+0.01+0.36%
ENTX
Entera Bio Ltd
1.83+0.08+4.57%
LBPH
Longboard Pharmaceuticals Inc
3.52-0.02-0.56%